Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trialRené Adam, Ephrem Salamé, Petru Bucur et al.|The Lancet|2024Cited by 153
Factors influencing recurrence following initial hepatectomy for colorectal liver metastasesJulie Hallet, Marc Pocard, António Sá Cunha et al.|British journal of surgery|2016Cited by 100
<i>BRAF</i> mutation is not associated with an increased risk of recurrence in patients undergoing resection of colorectal liver metastasesStéphane Benoist, Nathan Moreno-Lopez, Luca Viganò et al.|British journal of surgery|2019Cited by 42